Cannabis Law Report

NOVEMBER 10, 2019

Europe Cannabis and Pain Management Devices on Cancer Pain Market Report 2019 is dispensed after a thorough study of various key market segments such as market size, latest trends, market threats and key drivers driving the Europe Cannabis and Pain Management Devices on Cancer Pain market. UNIMED PHARMACEUTICALS.

Pharmaceutical 45

Pharmaceutical Research and Development Data Business 45

Cannabis Law Report

JANUARY 4, 2022

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Since March 2019, Mr. Allen has served as Chief Business Officer of Ambrx Biopharma Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. and Australia. Rex Merchant. Chief Financial Officer.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

Cannabis Law Report

JULY 19, 2019

July 18, 2019 (GLOBE NEWSWIRE) — ICC International Cannabis Corp. Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form.

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

JULY 21, 2019

ICC International Cannabis Corp. FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”).

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Medical cannabis costs family £4,000 a month to help teenager. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 254

Law Patients Access Oil 254

Cannabis Law Report

JULY 23, 2019

(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. Benefits of the Transaction. The Transaction.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. The Georgia State Board of Pharmacy recently made the decision to endorse more cannabis oil sale outlets. Its conversion into low-THC cannabis oil also allowed for treating many diseases.

Oil 98

Oil Patients Access THC 98

Cannabis Law Report

NOVEMBER 5, 2019

Cabot Wealth Management Inc increased its stake in Gw Pharmaceuticals Plc (GWPH) by 34.2% The institutional investor held 20,865 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $3.60M, up from 15,548 at the end of the previous reported quarter. based on its latest 2019Q2 regulatory filing with the SEC.

Pharmaceutical 45

Pharmaceutical Epilepsy Treatment Medicine 45

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. 2 Goates et al. Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

MAY 30, 2019

. – May 29, 2019) – Benchmark Botanics, Inc. This definitive agreement solidifies the terms of the Letter of Intent of Strategic Cooperation between Benchmark and Zhejian Yatai, which was reported in a news release on May 7, 2019. million CAD); and Rippington Investment (“RI”) will invest $3.5

Pharmaceutical 40

Pharmaceutical Research and Development Extraction Cultivation 40

Cannabis Law Report

DECEMBER 23, 2019

Posted by Alexa Steinberg, Esq. | Dec 20, 2019 . To kick us off, hemp was legalized at the federal level, and we entered into unchartered territory, navigating uncertain waters of the newest arm of the cannabis industry with a lack of regulation or guidance. TOP Defining Moments in Los Angeles Cannabis.

Law 59

Law Banking Hemp Retail 59

Cannabis Law Report

SEPTEMBER 29, 2021

Ganajapreneur reports… The Securities and Exchange Commission (SEC) is accusing the co-founders of C3, a company that makes cannabis pill Idrasil , of $2 million in securities fraud, Law360 reports. Idrasil was not an approved pharmaceutical by the insurance companies. Read full article at .

Pharmaceutical 98

Pharmaceutical Cannabis Business Law 98

Cannabis Law Report

MAY 17, 2019

PUBLISHER: CANNABIS LAW REPORT. With the growing number of states legalizing marijuana for medical and recreational use, many brands have emerged for cannabis and related goods and services. For marks used for cannabis products above 0.3% For marks used for cannabis products above 0.3% AUTHOR: Joshua B.

Hemp 63

Hemp THC Sativa Cannabis 63

Cannabis Law Report

SEPTEMBER 12, 2019

11, 2019 /PRNewswire/ – Aurora Cannabis Inc. the “ Company ” or “ Aurora “) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today its financial and operational results for the fourth quarter and fiscal year ended June 30, 2019.

Research and Development 45

Research and Development Extraction Cannabis Wellness and Beauty 45

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 13, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

The Blunt Truth

OCTOBER 3, 2019

Plus, a new bill would legalize cannabis with state-run stores. In Minnesota , lawmakers are conducting “Be Heard on Cannabis” discussions, so that citizens can share their views on legal marijuana. Also in New Mexico , growers of medical cannabis are suing the state over limits on plant-count.

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

Cannabis Law Report

JULY 7, 2022

January 2019. Eleven of thirteen cannabis patent claims survive PTAB challenge. filed a petition requesting inter partes review of claims 1-13 of GW Pharmaceutical Ltd.’s As the first post-grant trial on medicinal cannabis, this decision thus removes a few unknowns for those who own or are seeking patents in this space. [i]

Epilepsy 52

Epilepsy Pharmaceutical Treatment Cannabinoids 52

Project CBD

MARCH 8, 2019

In recent years, the use of cannabis in veterinary medicine has gone from obscure concept to a mainstream issue. This explosion of interest in the use of cannabis and CBD for animals has led to the development of a multi-million dollar industry creating cannabis-based products for pets. Medical Cannabis in California.

Pets 215

Pets Legalization Hemp Extraction 215

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. 30 May 2019. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

The Cannigma

DECEMBER 4, 2022

Recreational cannabis is illegal in Romania. The country technically legalized medical cannabis with less than 0.2% Another draft law was introduced in 2019 to expand the program; as of 2022, it was still in draft in a chamber of government. Selling cannabis can mean jail time of up to 12 years. Possible penalties.

Law 59

Law Seed-To-Sale Programs Tincture 59

Cannabis Law Report

JUNE 24, 2021

Luxembourg is scrambling to secure a new medical cannabis supplier after encountering delays of up to 60 days, leaving new patients empty-handed. Health minister Paulette Lenert (LSAP) responded to a parliamentary question that the country was facing three types of medicinal cannabis bottlenecks. Website Delano reports.

Medicine 104

Medicine Chronic Pain Treatment Patients 104

Cannabis Law Report

NOVEMBER 23, 2019

for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA and standardised cannabis.

Pharmaceutical 45

Pharmaceutical Research and Development Cultivation Environment 45

The Cannigma

OCTOBER 14, 2022

Recreational cannabis is not legal, despite a 2019 citizen’s initiative that called for legalization. In 2019 the Parliament approved a citizen’s proposal to regulate recreational use of cannabis, but backtracked in March 2020 , saying they would wait to follow the lead of Italy. Can you bring or buy cannabis products?

Law 56

Law Clinical Trials Research and Development Recreational 56

NORML

FEBRUARY 14, 2019

SB1719 allows “registered agents” for those patients physically unable to pick up or receive delivery of their medical cannabis, like those in hospice, assisted living facilities, and those who rely on home healthcare providers. ” Other medical cannabis-related bills are still making their way through the legislature. .

Access 198

Access Patients Legislation Medicine 198

Cannabis Law Report

APRIL 28, 2022

DEMECAN’s first cannabis shipment to the BfArM is ready for collection and includes more than 100 kg of cannabis flowers. High-quality cannabis flowers from DEMECAN’s German high-end facility are now available to patients. 2500 cannabis plants are now growing in its own flower rooms in Saxony.

Pharmaceutical 52

Pharmaceutical Cultivation Collective Patients 52

Cannabis Law Report

JUNE 22, 2022

New Zealand’s Helius Therapeutics is teaming up with local biotechnology company Greenlab on medicinal cannabis genetic development and breeding. Helius was the first medicinal cannabis company in New Zealand to achieve GMP certification and be awarded a Licence to Manufacture Medicines. Hemop Gazette.

Research and Development 52

Research and Development Pharmaceutical Medicine Cultivation 52

Cannabis Law Report

JUNE 1, 2021

There isn’t much writing at all on Brazilian policy issues regarding cannabis so this is well worth spending some time with. Renato Malcher-Lopes and Sidarta Ribeiro (2019) point out that, to some extent, it was common for healers to prescribe marijuana to cure various types of diseases. Here’s their introduction.

Medicine 95

Medicine Decriminalization Pharmaceutical Marijuana 95

Cannabis Law Report

DECEMBER 2, 2021

Generally, medicinal cannabis products are only available, on prescription, if they have: been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or. MW Pharma Limited t/a NUBU Pharmaceuticals. CDC Pharmaceuticals Ltd.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Cannabis Law Report

JULY 4, 2021

Cannabis stocks have welcomed the change in ownership of Pershing Australia from Bank of New York Mellon (BNYM) to Finclear Pty Ltd which – effective immediately – will allow the trading of cannabis securities on the ASX. Cannabis stocks celebrate Pershing ownership change.

Banking 105

Banking Pharmaceutical Cannabis Policy 105

Cannabis Law Report

DECEMBER 19, 2021

17 December 2021: New medicinal cannabis products have been verified as meeting the minimum quality standard – Read more. Medicinal cannabis products that meet the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019. MW Pharma Limited t/a NUBU Pharmaceuticals. 4 Oct 2021.

Medicine 52

Medicine Pharmaceutical THC Sativa 52

Veriheal

JANUARY 12, 2023

The people of French Polynesia can now legally use medicinal cannabis following the local assembly’s approval of a consumption law. The law also permits the agricultural production of cannabis and hemp for industrial purposes, with a heavy emphasis on pharmaceutical crops. .

Medicine 96

Medicine Chronic Pain Consumption Cannabis 96

Cannabis Law Report

OCTOBER 6, 2019

Organizer: Heilongjiang Science and Technology Department / China Industrial Cannabis Industry Alliance. China is the main cannabis planting area in the world, accounting for about half of the total area planted. Of the 606 patents involving cannabis, 309 came from enterprises and individuals in China.

Hemp 45

Hemp Research and Development Education Cultivation 45

Cannabis Law Report

APRIL 20, 2022

South Australian firm MedTEC Pharma has signed a A$10m product supply contract with an unnamed “world-leading pharmaceutical business” ahead of a possible IPO next year. The Herald Sun reports the parties have agreed a three-year deal for cannabis biomass to be delivered from MedTEC’s production facility in SA’s Riverland region.

Research and Development 52

Research and Development Pharmaceutical Cultivation Medicine 52

Cannabis Law Report

FEBRUARY 5, 2020

UK medicinal cannabis company Eco Equity founder Jon-Paul Doran has launched his first exclusively medical cannabis fund, JPD Capital, in London. Minimum investment into the medical cannabis fund is £25,000 and investors can be based anywhere in the world. Exclusive medical cannabis fund.

Seed-To-Sale 59

Seed-To-Sale Pharmaceutical Medicine Cultivation 59

The Blunt Truth

AUGUST 19, 2021

California refuses to allow cannabis in prisons. And finally, if you’d like to use your iPhone to buy cannabis, there’s an app for that. But, in the agency’s view, that approval as an active ingredient in a pharmaceutical means it cannot approve it as a dietary supplement. cannabis in california prisons. the fda and cbd.

Pharmaceutical 111

Pharmaceutical Food CBD Retail 111